Clinical trials
Multiple Myeloma trials in Denmark
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
120 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2004 | 1 |
| 2005 | 3 |
| 2007 | 3 |
| 2008 | 3 |
| 2009 | 5 |
| 2010 | 4 |
| 2011 | 6 |
| 2012 | 4 |
| 2013 | 3 |
| 2014 | 5 |
| 2015 | 10 |
| 2016 | 5 |
| 2017 | 8 |
| 2018 | 4 |
| 2019 | 7 |
| 2020 | 5 |
| 2021 | 8 |
| 2022 | 9 |
| 2023 | 8 |
| 2024 | 4 |
| 2025 | 3 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 59 |
| Active, not recruiting | 21 |
| Recruiting | 17 |
| Terminated | 10 |
| Unknown status | 7 |
| Not yet recruiting | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Janssen Research & Development, LLC | 13 |
| Celgene | 12 |
| Thomas Lund | 6 |
| AbbVie | 5 |
| Nordic Myeloma Study Group | 5 |
| Bristol-Myers Squibb | 4 |
| Genentech, Inc. | 4 |
| Henrik Gregersen | 4 |
| Odense University Hospital | 4 |
| Vejle Hospital | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 120 |
| Recurrence | 19 |
| Neoplasms, Plasma Cell | 10 |
| Neoplasms | 9 |
| Hematologic Neoplasms | 6 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 6 |
| Leukemia, Myeloid, Acute | 6 |
| Lymphoma | 6 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 |
| Waldenstrom Macroglobulinemia | 5 |
Trials
Showing 1 to 25 of 120. Each trial links to its page on Pharma Observatory.
20 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.